Furanone compounds and lactam analogues thereof

Details for Australian Patent Application No. 2007304839 (hide)

Owner Biosignal Limited

Inventors Kumar, Naresh; Iskander, George

Agent Davies Collison Cave

Pub. Number AU-A-2007304839

PCT Pub. Number WO2008/040097

Priority 2006905579 06.10.06 AU

Filing date 8 October 2007

Wipo publication date 10 April 2008

International Classifications

C07D 307/58 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

A61K 31/341 (2006.01) - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

A61K 31/365 (2006.01) - Lactones

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/4025 (2006.01) - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/10 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 33/02 (2006.01) Antiparasitic agents

C07D 207/38 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 405/04 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 407/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

C07D 409/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

4 June 2009 PCT application entered the National Phase

  PCT publication WO2008/040097 Priority application(s): WO2008/040097

6 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

15 March 2012 Section 223 Application Received

  Biosignal Limited An application to extend the time from 01 Sep 2011 to 01 Jan 2012 in which to request examination has been filed . Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000

5 April 2012 Section 223 Application Allowed

  Biosignal Limited The time in which to request examination has been extended to 01 Jan 2012. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000 Extensions of Time, Section 223 2008

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007304847-Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity

2007304837-Molecular switches and methods for their use